Enzo Biochem, Inc.
ENZ was delisted on the 17th of April, 2025.
86 hedge funds and large institutions have $90.4M invested in Enzo Biochem, Inc. in 2014 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 31 increasing their positions, 11 reducing their positions, and 9 closing their positions.
256% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 9
182% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 11
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
94% more call options, than puts
Call options by funds: $531K | Put options by funds: $274K
63% more capital invested
Capital invested by funds: $55.3M → $90.4M (+$35.1M)
37% more funds holding
Funds holding: 63 → 86 (+23)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$3.26M |
| 2 |
KIA
Kopp Investment Advisors
Bloomington,
Minnesota
|
+$2.04M |
| 3 |
CPIM
Columbia Partners Investment Management
Alexandria,
Virginia
|
+$1.84M |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$1.35M |
| 5 |
State Street
Boston,
Massachusetts
|
+$1.31M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$1.58M |
| 2 |
WA
Whitebox Advisors
Minneapolis,
Minnesota
|
-$753K |
| 3 |
PRC
Platte River Capital
Denver,
Colorado
|
-$514K |
| 4 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
-$432K |
| 5 |
CFB
Cullen/Frost Bankers
San Antonio,
Texas
|
-$428K |
ENZ Hedge Fund Activity: Q2 2014 in Review
86 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem, Inc. (ENZ) for Q2 2014, worth a combined $90.4M — up 63% from $55.3M a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new ENZ positions and 9 closed out — a net gain of 23 holders — while 31 added to existing stakes and 11 trimmed.
The largest buyer was BlackRock Fund Advisors, adding an estimated $3.26M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $1.58M sold.
- 86 institutional investors held Enzo Biochem, Inc. (ENZ) as of Q2 2014, up from 63 in Q1 2014.
- Funds reported $90.4M of Enzo Biochem, Inc. stock for Q2 2014, up 63% quarter-over-quarter.
- 32 funds opened new Enzo Biochem, Inc. positions in Q2 2014 and 9 closed out, a net change of +23 holders.
- The largest Enzo Biochem, Inc. buyer in Q2 2014 was BlackRock Fund Advisors, an estimated $3.26M added.
- The largest Enzo Biochem, Inc. seller in Q2 2014 was Perceptive Advisors, an estimated $1.58M sold.
Based on aggregated 13F filings for Q2 2014.